Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6660842B1 · kind B1 · utility
17Cited by
49References
34Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 19, 2000 |
| Grant date | Dec 9, 2003 |
| Priority date | — |
| Expiry date | Sep 19, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/825
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention generally relates to compositions and methods for preventing and treating human diseases including, but not limited to, pathogens such as bacteria, yeast, parasites, fungus, viruses, and cancer. More specifically, embodiments described herein concern the manufacture and use of ligand/receptor specificity exchangers, which redirect existing antibodies in a subject to receptors present on pathogens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.